Germany vs Netherlands: Reported rate of new cervical cancer cases
Germany
7.49 per 100,000 women
in 2017
Netherlands
6.93 per 100,000 women
in 2017
Germany rank
24th
Netherlands rank
26th
Reported rate of new cervical cancer cases over time
- Germany
- Netherlands
How they compare
Germany currently reports 7.49 per 100,000 women against 6.93 per 100,000 women in Netherlands, a difference of 0.56 per 100,000 women.
That makes Germany's figure about 1.1 times Netherlands's.
Across all 15 years both countries report, Germany has been ahead every year.
Germany ranks 24th and Netherlands ranks 26th of 46 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.54 per 100,000 women | 5.92 per 100,000 women | 2.62 per 100,000 women | Germany |
| 2010s | 8.03 per 100,000 women | 6.54 per 100,000 women | 1.48 per 100,000 women | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Germany or Netherlands?
- Germany, at 7.49 per 100,000 women against 6.93 per 100,000 women in Netherlands as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Germany and Netherlands?
- 0.56 per 100,000 women, with Germany ahead.
- How many years of comparable data are there for Germany and Netherlands?
- 15 years are reported by both, from 2003 to 2017.
- How do Germany and Netherlands rank globally for reported rate of new cervical cancer cases?
- Germany ranks 24th and Netherlands ranks 26th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.